Boston Scientific (BSX) Announces Late-Breaking Data for HeartLogic Heart Failure Diagnostic

September 19, 2017 9:26 AM EDT Send to a Friend
Boston Scientific (NYSE: BSX) today announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login